Anti-HCV IgG avidity index in acute hepatitis C

Journal of Clinical Virology

Volumn 40, Issue 2, 2007, Pages 110-115

  Coppola, Nicola ^a   Pisapia, Raffaella ^a   Marrocco, Cecilia ^a   Martini, Salvatore ^a,b   Vatiero, Luisa Maria ^a,b   Messina, Vincenzo ^b   Tonziello, Gilda ^a,b   Sagnelli, Caterina ^a   Filippini, Pietro ^a   Piccinino, Felice ^a   Sagnelli, Evangelista ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Azienda Ospedaliera San Sebastiano   (Italy)

Author keywords

Acute hepatitis C; Anti HCV; Antibody avidity; Chronic hepatitis C; HCV avidity index; Reactivation of chronic hepatitis C

Indexed keywords

GUANIDINE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G;

ACUTE HEPATITIS; ADULT; ANTIBODY DETECTION; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 34548693175     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.07.005     Document Type: Article

References (28)

1. Coppola N., Vatiero L.M., and Sagnelli E. HCV genotype 2 as a risk factor for reactivation of chronic HCV infection. GUT 54 (2005) 1207
2. Eggers M., Baeder U., and Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 60 (2000) 324-330
3. Gerlach J.T., Diepolder H.M., Zachoval R., Gruener N.H., Jung M.C., Ulsenheimer A., et al. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125 (2003) 80-88
4. Grebely J., Conway B., Raffa J.D., Lai C., Krajden M., and Tyndall M.W. Hepatitis C virus reinfection in injection drug abuse. Hepatology 44 (2006) 1139-1145
5. Herring B.L., Shafer K.G., Tobler L.H., and Delwart E.L. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 190 (2004) 1396-1403
6. Hiraga N., Suzuki F., Akuta N., Suzuki Y., Sesaki Y., Hosaka T., et al. Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up. J Med Virol 75 (2005) 240-248
7. Hofer H., Watkins-Riedel T., Janata O., Penner E., Holzmann H., Steindl-Munda P., et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 37 (2003) 60-64
8. Jaeckel E., Cornerberg M., Wedemeyer H., Santantonio T., Mayer J., Zankel M., et al., The German Acute Hepatitis C Therapy Group. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345 (2001) 1452-1457
9. Jenum P.A., Stray-Pedersen B., and Gundersen A.G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J. Clin. Microbiol 35 (1997) 1972-1977
10. Kamal S.M., Fouly A.E., Kamel R.R., Hockenjos B., Tawil A.A., Khalifa K.E., et al. Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virological response. Gastroenterology 130 (2006) 632-638
11. Kamal S.M., Ismail A., Graham C.S., He Q., Rasenack J.W., Peters T., et al. Pegylated interferon α therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics. Hepatology 39 (2004) 1721-1731
12. Kangro H.O., Manzoor S., and Harper D.R. Antibody avidity following varicella zoster virus infections. J Med Virol 33 (1991) 100-105
13. Kanno A., Kazuyama Y., and Immunoglobulin. G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol 68 (2002) 229-233
14. Mondelli M.U., Cerino A., and Cividini A. Acute hepatitis C: diagnosis and management. J Hepatol 42 (2005) 108-114
15. Orland J.R., Wright T.L., and Cooper S. Acute hepatitis C. Hepatology 33 (2001) 321-327
16. Puchhammer-Stockl E., Schmied B., Rieger A., Sarcletti M., Geit M., Zangerle R., et al. Low proportion of recent human immunodeficiency virus (HIV) infections among newly diagnosed cases of HIV infection as shown by the presence of HIV-specific antibodies of low avidity. J Clin Microbiol 43 (2005) 497-498
17. Rodella A., Galli C., Terlenghi L., Perandin F., Bonfanti C., and Manca N. Quantitative analysis of HBsAg, IgM anti-HBc and anti-Hbc avidity in acute and chronic hepatitis B. J Clin Virol 37 (2006) 206-212
18. Rumi M.G., De Filippi F., Donato M.F., Del Ninno E., and Colombo M. Progressive hepatic fibrosis in healthy carriers of hepatitis C virus with a transaminase breakthrough. J Viral Hep 9 (2002) 71-74
19. Rumi M.G., De Filippi F., La Vecchia C., Donato M.F., Gallus S., Del Ninno E., et al. Hepatitis C reactivation in patients with chronic infection with genotype 1b and 2c: a retrospective cohort study of 206 untreated patients. GUT 54 (2005) 402-406
20. Sagnelli E., Coppola N., Marrocco C., Coviello G., Battaglia M., Messina V., et al. Diagnosis of HCV related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 42 (2005) 646-651
21. Santantonio T., Medda E., Ferrari C., Fabris P., Cariti G., Massari M., et al. Risk factor and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis 43 (2006) 1154-1159
22. Sheen I.S., Liaw Y.F., Lin D.Y., and Chu C.M. Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study. J Hepatol 24 (1996) 525-531
23. Simmonds P., Alberti A., Alter H.J., Bonino F., Bradley D.W., Brechot C., et al. A proposed system for nomenclature of hepatitis C viral genotypes. Hepatology 19 (1994) 1321-1324
24. Suligoi B., Galli C., Massi M., Di Sora F., Sciandra M., Pezzetti P., et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 40 (2002) 4015-4020
25. Suligoi B., Massi M., Galli M., Sciandra M., Di Sora F., Pezzetti P., et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J. Acquir Immune Defic Syndr 32 (2003) 424-428
26. Thomas H.I.J. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection. J Med Virol 51 (1997) 189-197
27. Ward K.N., Dhaliwal W., Ashworth K.L., Clutterbuck E.J., and Teo C.G. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 43 (1994) 367-372
28. Ward K.N., Turner D.J., Couto Parada X., and Thiruchelvam D. Use of immunoglobulin G antibody avidity for differentiation of primary human herpes virus 6 and 7 infections. J Clin Microbiol 39 (2001) 959-963